Catalytic asymmetric synthesis of α-methyl-p-boronophenylalanine

Bioorg Med Chem Lett. 2018 Jun 1;28(10):1915-1918. doi: 10.1016/j.bmcl.2018.03.075. Epub 2018 Mar 28.

Abstract

p-Boronophenylalanine (l-BPA) is applied in clinical settings as a boron carrier for boron neutron capture therapy (BNCT) to cure malignant melanomas. Structural modification or derivatization of l-BPA, however, to improve its uptake efficiency into tumor cells has scarcely been investigated. We successfully synthesized (S)-2-amino-3-(4-boronophenyl)-2-methylpropanoic acid in enantioenriched form as a novel candidate molecule for BNCT. Key steps to enhance the efficiency of this synthesis were enantioselective alkylation of N-protected alanine tert-butyl ester with a Maruoka catalyst and Miyaura borylation reaction to install the boron functionality.

Keywords: BNCT; BPA; Drug delivery; Miyaura borylation; Phase transfer catalysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkylation
  • Boron Compounds / chemical synthesis
  • Boron Compounds / chemistry*
  • Catalysis
  • Coordination Complexes / chemistry
  • Palladium / chemistry
  • Phenylalanine / analogs & derivatives*
  • Phenylalanine / chemical synthesis
  • Phenylalanine / chemistry
  • Stereoisomerism

Substances

  • Boron Compounds
  • Coordination Complexes
  • Phenylalanine
  • Palladium
  • 4-boronophenylalanine